Discover
BLFS
BioLife Solutions, Inc.
38.61
2 x 27.79
2 x 47.06
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
28.10 -10.51 (27.22%)
| Ytd | 0.00% | |
| 1y | 0.00% |
36.96
day range
38.83
38.61
52 week range
38.61
| Open | Prev Close | 38.61 | Low | 36.96 | High | 38.83 | Mkt Cap | 1.89B | |
| Vol | 0.00 | Avg Vol | 1.12M | EPS | 0.99 | P/E | 39.00 | Forward P/E | 117.00 |
| Beta | 1.82 | Short Ratio | 4.54 | Inst. Own | 105.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 36.08 | 200-d Avg | 26.77 | 1yr Est | 31.00 |
| Income Statement | |||
| Total Revenue | 28.47M | ||
| Revenues (USD) | 28.47M | ||
| Cost of Revenue | 10.18M | ||
| Gross Profit | 18.29M | ||
| Operating Expenses | 16.59M | ||
| Research and Development Expense | 2.96M | ||
| Selling, General and Administrative Expense | 13.48M | ||
| Operating Income | 1.70M | ||
| Interest Expense | -994.00K | ||
| Income Tax Expense | -42.35M | ||
| Net Income | 45.10M | ||
| Net Income Common Stock | 45.10M | ||
| Net Income Common Stock (USD) | 45.10M | ||
| Consolidated Income | 45.10M | ||
| Earnings per Basic Share | 0.92 | ||
| Earnings per Basic Share (USD) | 0.92 | ||
| Earnings per Diluted Share | 0.91 | ||
| Earning Before Interest & Taxes (EBIT) | 1.76M | ||
| Earning Before Interest & Taxes (USD) | 1.76M | ||
| Weighted Average Shares | 48.87M | ||
| Weighted Average Shares Diluted | 49.29M | ||
| Balance Sheet | |||
| Cash and Equivalents | 24.00M | ||
| Cash and Equivalents (USD) | 24.00M | ||
| Investments | 89.07M | ||
| Investments Current | 58.42M | ||
| Investments Non-Current | 30.65M | ||
| Trade and Non-Trade Receivables | 10.65M | ||
| Current Assets | 135.20M | ||
| Property, Plant & Equipment Net | 23.88M | ||
| Total Assets | 447.49M | ||
| Debt Current | 2.59M | ||
| Total Debt | 15.74M | ||
| Current Liabilities | 13.95M | ||
| Debt Non-Current | 13.15M | ||
| Total Liabilities | 27.49M | ||
| Accumulated Retained Earnings (Deficit) | -293.41M | ||
| Accumulated Other Comprehensive Income | -211.00K | ||
| Shareholders Equity | 420.00M | ||
| Shareholders Equity (USD) | 420.00M | ||
| Assets Non-Current | 312.30M | ||
| Total Debt (USD) | 15.74M | ||
| Goodwill and Intangible Assets | 212.24M | ||
| Inventory | 35.59M | ||
| Liabilities Non-Current | 13.54M | ||
| Trade and Non-Trade Payables | 2.48M | ||
| Tax Assets | 42.23M | ||
| Tax Liabilities | 2.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.47M | ||
| Net Cash Flow from Financing | -3.59M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.18M | ||
| Capital Expenditure | -1.04M | ||
| Issuance (Purchase) of Equity Shares | 3.00K | ||
| Issuance (Repayment) of Debt Securities | -2.50M | ||
| Net Cash Flow from Investing | -1.58M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -416.00K | ||
| Net Cash Flow from Operations | 6.35M | ||
| Share Based Compensation | 3.85M | ||